Metrovacesa (BME: MVC) revenue
Metrovacesa reported revenue of €676.4m for fiscal 2025, 15.0% more than in fiscal 2024 (€588.1m). Since fiscal 2020 its revenue has grown by 419.2%, an average growth of 39.0% a year.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | €676.4m | +15.0% | €127.6m | 18.9% |
| 2024 | €588.1m | +17.1% | €73.4m | 12.5% |
| 2023 | €502.4m | +13.8% | €74.2m | 14.8% |
| 2022 | €441.5m | −6.5% | €45.8m | 10.4% |
| 2021 | €472.2m | +262.4% | −€50.8m | −10.8% |
| 2020 | €130.3m | — | −€7.8m | −6.0% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of euros, except per-share amounts.
Questions about the revenue of Metrovacesa
- How much revenue did Metrovacesa make in fiscal 2025?
- Metrovacesa reported revenue of €676.4m for fiscal 2025, compared with €588.1m in fiscal 2024.
- How much has the revenue of Metrovacesa grown?
- Between fiscal 2020 and fiscal 2025 it went from €130.3m to €676.4m: 419.2% more, an average growth of 39.0% a year.
- What was the best year for revenue at Metrovacesa?
- Of its last 6 fiscal years, fiscal 2025, with €676.4m.
- Where do the figures for Metrovacesa come from?
- From the report Metrovacesa files every year in the European single electronic format (ESEF), the same one the CNMV, the Spanish regulator, receives. Each fiscal year links to its filing.
Where each figure comes from
From the annual report Metrovacesa files every year in the European single electronic format (ESEF). The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021. More on Metrovacesa: the Metrovacesa page · annual accounts · net income · dividends paid.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.